Yu Hou

1.5k total citations · 2 hit papers
55 papers, 1.0k citations indexed

About

Yu Hou is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Yu Hou has authored 55 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 14 papers in Cancer Research and 12 papers in Hematology. Recurrent topics in Yu Hou's work include Acute Myeloid Leukemia Research (10 papers), MicroRNA in disease regulation (8 papers) and Cancer-related molecular mechanisms research (7 papers). Yu Hou is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), MicroRNA in disease regulation (8 papers) and Cancer-related molecular mechanisms research (7 papers). Yu Hou collaborates with scholars based in China, United States and United Kingdom. Yu Hou's co-authors include Zhe Chen, Jieping Chen, C. C. Huang, Hanhua Cheng, Rongjia Zhou, Guanbin Song, Weiru Wu, Chunli Gong, Yang Chen and Yongxiu Huang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Yu Hou

51 papers receiving 1.0k citations

Hit Papers

Demethylase ALKBH5 suppresses invasion of gastric cancer ... 2022 2026 2023 2024 2022 2024 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Hou China 20 680 287 109 105 103 55 1.0k
Maria Mesuraca Italy 20 631 0.9× 181 0.6× 155 1.4× 73 0.7× 129 1.3× 41 966
Majid Farshdousti Hagh Iran 20 733 1.1× 251 0.9× 86 0.8× 71 0.7× 176 1.7× 57 1.1k
Laurens T. van der Meer Netherlands 12 744 1.1× 204 0.7× 138 1.3× 44 0.4× 134 1.3× 24 1.2k
Yongjun Fang China 17 479 0.7× 273 1.0× 116 1.1× 46 0.4× 106 1.0× 75 852
Yuan Xia China 17 444 0.7× 225 0.8× 74 0.7× 54 0.5× 79 0.8× 70 856
Yan Jin China 23 773 1.1× 309 1.1× 51 0.5× 102 1.0× 262 2.5× 74 1.3k
Sarmishtha De United States 13 574 0.8× 166 0.6× 143 1.3× 53 0.5× 263 2.6× 22 1.1k
Ying‐Yu Ma China 20 619 0.9× 299 1.0× 29 0.3× 106 1.0× 204 2.0× 54 1.0k

Countries citing papers authored by Yu Hou

Since Specialization
Citations

This map shows the geographic impact of Yu Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Hou more than expected).

Fields of papers citing papers by Yu Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Hou. The network helps show where Yu Hou may publish in the future.

Co-authorship network of co-authors of Yu Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Hou. A scholar is included among the top collaborators of Yu Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Hou. Yu Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhao, Ruiying, Yifan Zheng, Yan Li, et al.. (2025). Targeting KPNB1 suppresses AML cells by inhibiting HMGB2 nuclear import. Oncogene. 44(21). 1646–1661.
3.
Li, Lei, Yan Li, Yuxin Xie, et al.. (2025). EMP1 safeguards hematopoietic stem cells by suppressing sphingolipid metabolism and alleviating endoplasmic reticulum stress. Nature Communications. 16(1). 6247–6247.
4.
Peng, Meixi, Yongxiu Huang, Zhengyu Chen, et al.. (2025). New insights into extracellular vesicles in metastatic cancer: From mechanisms to diagnostics and targeted therapies. Molecular Therapy. 33(10). 4731–4747.
5.
Peng, Meixi, Zhenyu Wang, Yongxiu Huang, et al.. (2024). A novel LGALS1-depended and immune-associated fatty acid metabolism risk model in acute myeloid leukemia stem cells. Cell Death and Disease. 15(7). 482–482. 7 indexed citations
6.
Zhou, Chengfang, Tao Yin, Jianming Wang, et al.. (2024). Nynrin preserves hematopoietic stem cell function by inhibiting the mitochondrial permeability transition pore opening. Cell stem cell. 31(9). 1359–1375.e8. 49 indexed citations breakdown →
7.
Hou, Yu, et al.. (2024). Post-transcriptional regulation of DEAD-box RNA helicases in hematopoietic malignancies. Genes & Diseases. 11(5). 101252–101252. 2 indexed citations
8.
Li, Zhigang, Wei Wang, Changlin Zhen, et al.. (2024). Essential role of Dhx16-mediated ribosome assembly in maintenance of hematopoietic stem cells. Leukemia. 38(12). 2699–2708. 23 indexed citations
9.
Guan, Yuqing, Wei Li, Wanying Lin, et al.. (2023). TRIM32 biallelic defects cause limb-girdle muscular dystrophy R8: identification of two novel mutations and investigation of genotype–phenotype correlation. Skeletal Muscle. 13(1). 10–10. 4 indexed citations
10.
Chen, Zhe, Qian Guo, Lei Li, et al.. (2023). Overcoming adaptive resistance in AML by synergistically targeting FOXO3A-GNG7-mTOR axis with FOXO3A inhibitor Gardenoside and rapamycin. Genes & Diseases. 11(1). 397–412. 6 indexed citations
12.
Chen, Zhe, Dawei Huo, Lei Li, et al.. (2021). Nuclear DEK preserves hematopoietic stem cells potential via NCoR1/HDAC3-Akt1/2-mTOR axis. The Journal of Experimental Medicine. 218(5). 31 indexed citations
13.
Luo, Chengxin, Guixian Wu, Yanni Ma, et al.. (2021). Efficacy and safety of new anti-CD20 monoclonal antibodies versus rituximab for induction therapy of CD20+ B-cell non-Hodgkin lymphomas: a systematic review and meta-analysis. Scientific Reports. 11(1). 3255–3255. 40 indexed citations
14.
Zhou, Chengfang, Zhilong Liu, Zhe Chen, et al.. (2021). Insufficiency of FZR1 disturbs HSC quiescence by inhibiting ubiquitin-dependent degradation of RUNX1 in aplastic anemia. Leukemia. 36(3). 834–846. 6 indexed citations
15.
Chen, Yingchun, et al.. (2020). Long-chain non-coding RNA HOTAIR promotes the progression of osteoarthritis via sponging miR-20b/PTEN axis. Life Sciences. 253. 117685–117685. 41 indexed citations
16.
Chen, Zhe, Lei Li, Shuangnian Xu, et al.. (2020). A Cdh1–FoxM1–Apc axis controls muscle development and regeneration. Cell Death and Disease. 11(3). 180–180. 26 indexed citations
17.
Hou, Yu, Jia Yuan, Xiang Zhou, et al.. (2012). DNA Demethylation and USF Regulate the Meiosis-Specific Expression of the Mouse Miwi. PLoS Genetics. 8(5). e1002716–e1002716. 32 indexed citations
18.
Tian, Yihao, Yu Hou, Xiang Zhou, Hanhua Cheng, & Rongjia Zhou. (2011). Tumor Suppressor RASSF1A Promoter: p53 Binding and Methylation. PLoS ONE. 6(2). e17017–e17017. 17 indexed citations
19.
Zhao, Wei, Fang Zhou, Xiang Zhou, et al.. (2010). Mago, a vertebrate homolog of Drosophila Mago nashi protein, is a component of the chromatoid body in the cytoplasm of the postmeiotic spermatid. Journal of Experimental Zoology Part B Molecular and Developmental Evolution. 314B(3). 232–241. 6 indexed citations
20.
Ying, Ming, Bo Chen, Yihao Tian, et al.. (2007). Nuclear import of human sexual regulator DMRT1 is mediated by importin-β. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1773(6). 804–813. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026